Latest News about JNJ
Recent news which mentions JNJ
From Motley Fool
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
From Motley Fool
3 Reasons to Rely on Dividend Stocks
January 18, 2024
From InvestorPlace
7 Must-Have Stocks for Serious Wealth Accumulation
January 18, 2024
From InvestorPlace
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
January 16, 2024
Tickers
JNJ
From Benzinga
The 3 Most Undervalued Value Stocks to Buy in January
January 15, 2024
From InvestorPlace
4 Fantastic Dividend King Stocks to Buy in 2024
January 15, 2024
From Motley Fool
Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends
January 14, 2024
From InvestorPlace
2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024
January 14, 2024
From Motley Fool
2 Average Stocks That Could Make You Rich
January 13, 2024
From Motley Fool
From InvestorPlace
Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January
January 11, 2024
From Motley Fool
Why Eli Lilly Stock Skyrocketed 59% in 2023
January 11, 2024
From Motley Fool
From Motley Fool
3 Unshakeable Dividend Stocks for Lifelong Wealth
January 10, 2024
From InvestorPlace
7 Stable Stocks to Buy No Matter What Happens to Interest Rates
January 10, 2024
From InvestorPlace
A Closer Look at Johnson & Johnson's Options Market Dynamics
January 10, 2024
Tickers
JNJ
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 09, 2024
From Benzinga
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit
January 09, 2024
From Benzinga
Want to Win in the Stock Market? Be Average.
January 09, 2024
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
January 08, 2024
From Benzinga
Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?
January 08, 2024
From InvestorPlace
J&J's Tentative $700M Agreement To Resolve Talc Powder-Related Lawsuits Across US States
January 08, 2024
From Benzinga
Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal
January 08, 2024
From Benzinga
From Benzinga
24 Top Dividend Stocks to Buy and Hold in 2024
January 07, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.